Stay updated on Avelumab First-line NSCLC Clinical Trial

Sign up to get notified when there's something new on the Avelumab First-line NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab First-line NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added and the previous revision v3.4.3 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T19:30:39.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new site revision entry (v3.4.3) was added to the history, replacing the previous revision (v3.4.2).
    Difference
    0.1%
    Check dated 2026-03-11T17:14:17.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history. The government-funding operating-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:14:34.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A government funding lapse notice was added, and the page revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:36:27.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    UI updates add a glossary display option, color-coded highlights for additions (green) and deletions (red), and an updated revision tag (v3.4.0) on the Record History page.
    Difference
    0.6%
    Check dated 2026-01-28T03:47:45.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision v3.3.4 is now listed in the Record History, replacing the prior v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:53:06.000Z thumbnail image

Stay in the know with updates to Avelumab First-line NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab First-line NSCLC Clinical Trial page.